AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne

PartnershipPositive

AI Analysis

Summary

AOB Pharma and Biorasi have partnered to advance a Phase 2b clinical trial for moderate to severe acne, accelerated ahead of schedule while maintaining the global Phase 3 timeline for atopic dermatitis.

Clinical Trial Data

Phase

Outcome Details

AOB Pharma and Biorasi partnering to run Phase 2b trial in moderate to severe acne

Importance:6/10

Sentiment:

0.60

partnershipPhase 2bacneatopic dermatitisclinical trial

Related Companies

$GMRE-PA

Read the original article

Published by PR Newswire Pharma on July 1, 2026 6:37 PM

Read Original